Cardamonin protects septic mice from acute lung injury by preventing endothelial barrier dysfunction

Journal of Biochemical and Molecular Toxicology

Volumn 26, Issue 7, 2012, Pages 282-290

  Wei, Zhifeng ^a   Yang, Jian ^a   Xia, Yu Feng ^a   Huang, Wen Zhe ^b   Wang, Zheng Tao ^b   Dai, Yue ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Acute lung injury; Cardamonin; P38MAPK; Sepsis

Indexed keywords

CARDAMONIN; FLAVONE DERIVATIVE; INTERLEUKIN 1BETA; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ACUTE LUNG INJURY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DRUG EFFECT; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; IN VITRO STUDY; LUNG ENDOTHELIUM; LUNG WEIGHT; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN PHOSPHORYLATION; RAT; SEPSIS; WESTERN BLOTTING;

ALPINIA KATSUMADAI; MUS; RATTUS;

EID: 84863994096     PISSN: 10956670     EISSN: 10990461     Source Type: Journal    
DOI: 10.1002/jbt.21420     Document Type: Article

References (36)

1. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992;101:1644-1655.
2. Awad SS. State-of-the-art therapy for severe sepsis and multisystem organ dysfunction. Am J Surg. 2003;186:23S-30S.
3. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 1994;149:818-824.
4. Wheeler AP, Bernard GR. Acute lung injury and the acute respiratory distress syndrome. Lancet. 2007;369:1553-1564.
5. Perl M, Lomas-Neira J, Chung CS, Ayala A. Epithelial cell apoptosis and neutrophil recruitment in acute lung injury-A unifying hypothesis? What we have learned from small interfering RNAs. Mol Med. 2008;14:465-475.
6. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med. 2000;342:1334-1349.
7. Cohen J. The immunopathogenesis of sepsis. Nature. 2002;420:885-891.
8. Groeneveld AB. Vascular pharmacology of acute lung injury and acute respiratory distress syndrome. Vasc Pharmacol. 2002;39:247-256.
9. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med. 2003;348:138-150.
10. Finigan JH. The coagulation system and pulmonary endothelial function in acute lung injury. Microvasc Res. 2009;77:35-38.
11. Regnault V, Levy B. Recombinant activated protein C in sepsis: endothelium protection or endothelium therapy? Crit Care. 2007;11:103.
12. Ahmad S, Israf DA, Lajis NH, Shari K, Mohamed H, Wahab AA, Ariffin KT, Hoo WY, Aziz NA, Kadir AA, Sulaiman MR, Somchit MN. Cardamonin, inhibits pro-inflammatory mediators in activated RAW 264.7 cells and whole blood. Eur J Pharmacol. 2006;538:188-194.
13. Hatziieremia S, Gray AI, Ferro VA, Paul A, Plevin R. The effects of cardamonin on lipopolysaccharide-induced inflammatory protein production and MAP kinase and NFkappaB signalling pathways in monocytes/macrophages. Br J Pharmacol. 2006;149:188-198.
14. Jantan I, Raweh SM, Sirat HM, Jamil S, Mohd Yasin YH, Jalil J, Jamal JA. Inhibitory effect of compounds from Zingiberaceae species on human platelet aggregation. Phytomedicine. 2008;15:306-309.
15. Huang WZ, Dai XJ, Liu YQ, Zhang CF, Zhang M, Wang ZT. Studies on antibacterial activity of flavonoids and diarylheptanoids from Alpinia katsumadai. J Plant Resour Environ. 2006;15:37-40.
16. Chen SF, Fei X, Li SH. A new simple method for isolation of microvascular endothelial cells avoiding both chemical and mechanical injuries. Microvasc Res. 1995;50:119-128.
17. Kim NS, Kim SJ. Isolation and cultivation of microvascular endothelial cells from rat lungs: effects of gelatin substratum and serum. Yonsei Med J. 1991;32:303-314.
18. Elizabeth MW, Gulnura K, John J, John B, Jessica M. Changes in lung permeability after chronic pulmonary artery obstruction. J Appl Physiol. 2006;100:1224-1229.
19. Gudgeon JR, Martin W. Modulation of arterial endothelial permeability: studies on an in vitro model. Br J Pharmacol. 1989;98:1267-1274.
20. Verbrugge SJ, Lachmann B, Kesecioglu J. Lung protective ventilatory strategies in acute lung injury and acute respiratory distress syndrome: from experimental findings to clinical application. Clin Physiol Funct Imaging. 2007;27:67-90.
21. Yang J, Dai Y, Xia YF, Huang WZ, Wang ZT. Alpinia katsumadai Hayata prevents mouse sepsis induced by cecal ligation and puncture through promoting bacterial clearance and downregulating systemic inflammation. Phytother Res 2009;23:267-273.
22. Matsuda N, Hattori Y. Vascular biology in sepsis: pathophysiological and therapeutic significance of vascular dysfunction. J Smooth Muscle Res. 2007;43:117-137.
23. Michel CC, Curry FE. Microvascular permeability. Physiol Rev. 1999;79:703-761.
24. Burrell R, Lantz RC, Hinton DE. Mediators of pulmonary injury induced by inhalation of bacterial endotoxin. Am Rev Respir Dis. 1988;137:100-105.
25. Goldblum SE, Ding X, Brann TW, Campbell-Washington J. Bacterial lipopolysaccharide induces actin reorganization, intercellular gap formation, and endothelial barrier dysfunction in pulmonary vascular endothelial cells: concurrent F-actin depolymerization and new actin synthesis. J Cell Physiol. 1993;157:13-23.
26. Hirano S, Rees RS, Yancy SL, Welsh MJ, Remick DG, Yamada T, Hata J, Gilmont RR. Endothelial barrier dysfunction caused by LPS correlates with phosphorylation of HSP27 in vivo. Cell Biol Toxicol. 2004;20:1-14.
27. Phillips PG, Lum H, Malik AB, Tsan MF. Phallacidin prevents thrombin-induced increases in endothelial permeability to albumin. Am J Physiol. 1989;257:C562-C567.
28. Welsh MJ, Gaestel M. Small heat-shock protein family: function in health and disease. Ann N Y Acad Sci. 1998;30:851:28-35.
29. Kostenko S, Moens U. Heat shock protein 27 phosphorylation: kinases, phosphatases, functions and pathology. Cell Mol Life Sci. 2009;20:3289-307.
30. Bogatcheva NV, Adyshev D, Mambetsariev B, Moldobaeva N, Verin AD. Involvement of microtubules, p38, and Rho kinases pathway in 2-methoxyestradiol-induced lung vascular barrier dysfunction. Am J Physiol Lung Cell Mol Physiol. 2007;2:L487-L499.
31. Wang T, Chiang ET, Moreno-Vinasco L, Lang GD, Pendyala S, Samet JM, Geyh AS, Breysse PN, Chillrud SN, Natarajan V, Garcia JG. Particulate matter disrupts human lung endothelial barrier integrity via ROS- and p38 MAPK-dependent pathways. Am J Respir Cell Mol Biol. 2010;4:442-449.
32. Cai H, Liu D, Garcia JG. CaM kinase II-dependent pathophysiological signalling in endothelial cells. Cardiovasc Res. 2008;77:30-34.
33. Kiemer AK, Weber NC, Fürst R, Bildner N, Kulhanek-Heinze S, Vollmar AM. Inhibition of p38 MAPK activation via induction of MKP-1: atrial natriuretic peptide reduces TNF-alpha-induced actin polymerization and endothelial permeability. Circ Res. 2002;90:874-881.
34. Huot J, Houle F, Marceau F, Landry J. Oxidative stress-induced actin reorganization mediated by the p38 mitogen-activated protein kinase/heat shock protein 27 pathway in vascular endothelial cells. Circ Res. 1997;80:383-392.
35. Lee JH, Jung HS, Giang PM, Jin X, Lee S, Son PT, Lee D, Hong YS, Lee K, Lee JJ. Blockade of nuclear factor-κB signaling pathway and anti-inflammatory activity of cardamomin, a chalcone analog from Alpinia conchigera. J Pharmacol Exp Ther. 2006;1:271-278.
36. Hirano S, Rees RS, Yancy SL, Welsh MJ, Remick DG, Yamada T, Hata J, Gilmont RR. Endothelial barrier dysfunction caused by LPS correlates with phosphorylation of HSP27 in vivo. Cell Biol Toxicol. 2004;1:1-14.